CereVasc Inc: Clinical Trials

5 trials sponsored by CereVasc Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting, 1 terminated. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Active not recruiting 4, Terminated 1

Follow CereVasc Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
CereVasc eShunt System, VP Shunt - Normal Pressure Hydrocephalus
Not applicableActive not recruitingCereVasc Inc2302024-11-262026-06-25
Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus
eShunt® Implant - Hydrocephalus, Hydrocephalus, Communicating
Not applicableTerminatedCereVasc Inc42022-09-152024-11-22
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
eShunt Implant - Hydrocephalus, Normal Pressure, Hydrocephalus
Not applicableActive not recruitingCereVasc Inc502022-04-202025-06-19
Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
eShunt Implant - Hydrocephalus, Normal Pressure, Hydrocephalus
Not applicableActive not recruitingCereVasc Inc302022-03-102026-03-18
The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)
eShunt™ Implant - Hydrocephalus, Communicating, Hydrocephalus
Not applicableActive not recruitingCereVasc Inc202020-10-012026-03-18

Conditions studied

Hydrocephalus (4)  ·  Hydrocephalus, Normal Pressure (3)

Interventions

Ventriculoperitoneal Shunt (1)

Countries

Argentina (3)  ·  United States (3)  ·  Canada (1)

Top investigators

Pedro Lylyk, MD (1)  ·  Pedro M Lylyk, MD (1)

Results publications

PMID 40135887, PMID 41734937, PMID 34862267